For instance, Joerger and Fersht (2016) demonstrated that certain TP53 mutations destabilize the protein’s core structure, impairing DNA binding and diminishing tumor-suppressor functions findings consistent with our computational predictions regarding structural disruptions and functional loss [31]. This evidence concerns the gene TP53 and neoplasm.